カテゴリー： Market Monitor Global, 世界, 医療/バイオ

処方薬の世界市場見通し2023年-2029年

◆英語タイトル：Prescription Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8595 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：124 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Prescription Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの処方薬市場規模と予測を収録しています。・世界の処方薬市場：売上、2018年-2023年、2024年-2029年
・世界の処方薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の処方薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ブランド医薬品」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

処方薬のグローバル主要企業は、Pfizer、 Roche、 Sanofi、 Johnson & Johnson、 Merck & Co. (MSD)、 Novartis、 AbbVie、 Gilead Sciences、 GlaxoSmithKline (GSK)、 Amgen、 AstraZeneca、 Bristol-Myers Squibb、 Eli Lilly、 Teva、 Bayer、 Novo Nordisk、 Allergan、 Takeda、 Boehringer Ingelheim、 Takedaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、処方薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の処方薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の処方薬市場：タイプ別市場シェア、2022年
・ブランド医薬品、ジェネリック医薬品

世界の処方薬市場：用途別、2018年-2023年、2024年-2029年
世界の処方薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の処方薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の処方薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における処方薬のグローバル売上、2018年-2023年
・主要企業における処方薬のグローバル売上シェア、2022年
・主要企業における処方薬のグローバル販売量、2018年-2023年
・主要企業における処方薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 Roche、 Sanofi、 Johnson & Johnson、 Merck & Co. (MSD)、 Novartis、 AbbVie、 Gilead Sciences、 GlaxoSmithKline (GSK)、 Amgen、 AstraZeneca、 Bristol-Myers Squibb、 Eli Lilly、 Teva、 Bayer、 Novo Nordisk、 Allergan、 Takeda、 Boehringer Ingelheim、 Takeda

*************************************************************

・調査・分析レポートの概要
処方薬市場の定義
市場セグメント
世界の処方薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の処方薬市場規模
世界の処方薬市場規模：2022年 VS 2029年
世界の処方薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの処方薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の処方薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ブランド医薬品、ジェネリック医薬品
処方薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
処方薬の用途別グローバル売上・予測

・地域別市場分析
地域別処方薬市場規模 2022年と2029年
地域別処方薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Roche、 Sanofi、 Johnson & Johnson、 Merck & Co. (MSD)、 Novartis、 AbbVie、 Gilead Sciences、 GlaxoSmithKline (GSK)、 Amgen、 AstraZeneca、 Bristol-Myers Squibb、 Eli Lilly、 Teva、 Bayer、 Novo Nordisk、 Allergan、 Takeda、 Boehringer Ingelheim、 Takeda
...

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
This report aims to provide a comprehensive presentation of the global market for Prescription Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Drugs. This report contains market size and forecasts of Prescription Drugs in global, including the following market information:
Global Prescription Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prescription Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prescription Drugs companies in 2022 (%)
The global Prescription Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Brand Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prescription Drugs include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Drugs Market Segment Percentages, by Type, 2022 (%)
Brand Drugs
Generic Drug
Global Prescription Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Prescription Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prescription Drugs revenues share in global market, 2022 (%)
Key companies Prescription Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prescription Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prescription Drugs, market overview.
Chapter 2: Global Prescription Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prescription Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Prescription Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Drugs Overall Market Size
2.1 Global Prescription Drugs Market Size: 2022 VS 2029
2.2 Global Prescription Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prescription Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Prescription Drugs Players in Global Market
3.2 Top Global Prescription Drugs Companies Ranked by Revenue
3.3 Global Prescription Drugs Revenue by Companies
3.4 Global Prescription Drugs Sales by Companies
3.5 Global Prescription Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prescription Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prescription Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prescription Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Prescription Drugs Market Size Markets, 2022 & 2029
4.1.2 Brand Drugs
4.1.3 Generic Drug
4.2 By Type – Global Prescription Drugs Revenue & Forecasts
4.2.1 By Type – Global Prescription Drugs Revenue, 2018-2023
4.2.2 By Type – Global Prescription Drugs Revenue, 2024-2029
4.2.3 By Type – Global Prescription Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Prescription Drugs Sales & Forecasts
4.3.1 By Type – Global Prescription Drugs Sales, 2018-2023
4.3.2 By Type – Global Prescription Drugs Sales, 2024-2029
4.3.3 By Type – Global Prescription Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Prescription Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prescription Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Prescription Drugs Revenue & Forecasts
5.2.1 By Application – Global Prescription Drugs Revenue, 2018-2023
5.2.2 By Application – Global Prescription Drugs Revenue, 2024-2029
5.2.3 By Application – Global Prescription Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Prescription Drugs Sales & Forecasts
5.3.1 By Application – Global Prescription Drugs Sales, 2018-2023
5.3.2 By Application – Global Prescription Drugs Sales, 2024-2029
5.3.3 By Application – Global Prescription Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Prescription Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Prescription Drugs Market Size, 2022 & 2029
6.2 By Region – Global Prescription Drugs Revenue & Forecasts
6.2.1 By Region – Global Prescription Drugs Revenue, 2018-2023
6.2.2 By Region – Global Prescription Drugs Revenue, 2024-2029
6.2.3 By Region – Global Prescription Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Prescription Drugs Sales & Forecasts
6.3.1 By Region – Global Prescription Drugs Sales, 2018-2023
6.3.2 By Region – Global Prescription Drugs Sales, 2024-2029
6.3.3 By Region – Global Prescription Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Prescription Drugs Revenue, 2018-2029
6.4.2 By Country – North America Prescription Drugs Sales, 2018-2029
6.4.3 US Prescription Drugs Market Size, 2018-2029
6.4.4 Canada Prescription Drugs Market Size, 2018-2029
6.4.5 Mexico Prescription Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Prescription Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Prescription Drugs Sales, 2018-2029
6.5.3 Germany Prescription Drugs Market Size, 2018-2029
6.5.4 France Prescription Drugs Market Size, 2018-2029
6.5.5 U.K. Prescription Drugs Market Size, 2018-2029
6.5.6 Italy Prescription Drugs Market Size, 2018-2029
6.5.7 Russia Prescription Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Prescription Drugs Market Size, 2018-2029
6.5.9 Benelux Prescription Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Prescription Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Prescription Drugs Sales, 2018-2029
6.6.3 China Prescription Drugs Market Size, 2018-2029
6.6.4 Japan Prescription Drugs Market Size, 2018-2029
6.6.5 South Korea Prescription Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Prescription Drugs Market Size, 2018-2029
6.6.7 India Prescription Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Prescription Drugs Revenue, 2018-2029
6.7.2 By Country – South America Prescription Drugs Sales, 2018-2029
6.7.3 Brazil Prescription Drugs Market Size, 2018-2029
6.7.4 Argentina Prescription Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Prescription Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Prescription Drugs Sales, 2018-2029
6.8.3 Turkey Prescription Drugs Market Size, 2018-2029
6.8.4 Israel Prescription Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Prescription Drugs Market Size, 2018-2029
6.8.6 UAE Prescription Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Prescription Drugs Major Product Offerings
7.1.4 Pfizer Prescription Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Prescription Drugs Major Product Offerings
7.2.4 Roche Prescription Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Prescription Drugs Major Product Offerings
7.3.4 Sanofi Prescription Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Prescription Drugs Major Product Offerings
7.4.4 Johnson & Johnson Prescription Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Company Summary
7.5.2 Merck & Co. (MSD) Business Overview
7.5.3 Merck & Co. (MSD) Prescription Drugs Major Product Offerings
7.5.4 Merck & Co. (MSD) Prescription Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck & Co. (MSD) Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Prescription Drugs Major Product Offerings
7.6.4 Novartis Prescription Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Prescription Drugs Major Product Offerings
7.7.4 AbbVie Prescription Drugs Sales and Revenue in Global (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Prescription Drugs Major Product Offerings
7.8.4 Gilead Sciences Prescription Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Company Summary
7.9.2 GlaxoSmithKline (GSK) Business Overview
7.9.3 GlaxoSmithKline (GSK) Prescription Drugs Major Product Offerings
7.9.4 GlaxoSmithKline (GSK) Prescription Drugs Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline (GSK) Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Prescription Drugs Major Product Offerings
7.10.4 Amgen Prescription Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Amgen Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Prescription Drugs Business Overview
7.11.3 AstraZeneca Prescription Drugs Major Product Offerings
7.11.4 AstraZeneca Prescription Drugs Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Company Summary
7.12.2 Bristol-Myers Squibb Prescription Drugs Business Overview
7.12.3 Bristol-Myers Squibb Prescription Drugs Major Product Offerings
7.12.4 Bristol-Myers Squibb Prescription Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Bristol-Myers Squibb Key News & Latest Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Company Summary
7.13.2 Eli Lilly Prescription Drugs Business Overview
7.13.3 Eli Lilly Prescription Drugs Major Product Offerings
7.13.4 Eli Lilly Prescription Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Eli Lilly Key News & Latest Developments
7.14 Teva
7.14.1 Teva Company Summary
7.14.2 Teva Business Overview
7.14.3 Teva Prescription Drugs Major Product Offerings
7.14.4 Teva Prescription Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Teva Key News & Latest Developments
7.15 Bayer
7.15.1 Bayer Company Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Prescription Drugs Major Product Offerings
7.15.4 Bayer Prescription Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Bayer Key News & Latest Developments
7.16 Novo Nordisk
7.16.1 Novo Nordisk Company Summary
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Prescription Drugs Major Product Offerings
7.16.4 Novo Nordisk Prescription Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Novo Nordisk Key News & Latest Developments
7.17 Allergan
7.17.1 Allergan Company Summary
7.17.2 Allergan Business Overview
7.17.3 Allergan Prescription Drugs Major Product Offerings
7.17.4 Allergan Prescription Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Allergan Key News & Latest Developments
7.18 Takeda
7.18.1 Takeda Company Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Prescription Drugs Major Product Offerings
7.18.4 Takeda Prescription Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Takeda Key News & Latest Developments
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Company Summary
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Prescription Drugs Major Product Offerings
7.19.4 Boehringer Ingelheim Prescription Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Boehringer Ingelheim Key News & Latest Developments
7.20 Takeda
7.20.1 Takeda Company Summary
7.20.2 Takeda Business Overview
7.20.3 Takeda Prescription Drugs Major Product Offerings
7.20.4 Takeda Prescription Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Takeda Key News & Latest Developments
8 Global Prescription Drugs Production Capacity, Analysis
8.1 Global Prescription Drugs Production Capacity, 2018-2029
8.2 Prescription Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Drugs Supply Chain Analysis
10.1 Prescription Drugs Industry Value Chain
10.2 Prescription Drugs Upstream Market
10.3 Prescription Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Prescription Drugs in Global Market
Table 2. Top Prescription Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prescription Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prescription Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Prescription Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Prescription Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prescription Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Prescription Drugs Product Type
Table 9. List of Global Tier 1 Prescription Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prescription Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Prescription Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Prescription Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Prescription Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Prescription Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Prescription Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Prescription Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Prescription Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Prescription Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Prescription Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Prescription Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prescription Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Prescription Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prescription Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Prescription Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Prescription Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Prescription Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prescription Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Prescription Drugs Product Offerings
Table 48. Pfizer Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Prescription Drugs Product Offerings
Table 52. Roche Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Prescription Drugs Product Offerings
Table 56. Sanofi Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Prescription Drugs Product Offerings
Table 60. Johnson & Johnson Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Merck & Co. (MSD) Company Summary
Table 63. Merck & Co. (MSD) Prescription Drugs Product Offerings
Table 64. Merck & Co. (MSD) Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck & Co. (MSD) Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Prescription Drugs Product Offerings
Table 68. Novartis Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. AbbVie Company Summary
Table 71. AbbVie Prescription Drugs Product Offerings
Table 72. AbbVie Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. AbbVie Key News & Latest Developments
Table 74. Gilead Sciences Company Summary
Table 75. Gilead Sciences Prescription Drugs Product Offerings
Table 76. Gilead Sciences Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Gilead Sciences Key News & Latest Developments
Table 78. GlaxoSmithKline (GSK) Company Summary
Table 79. GlaxoSmithKline (GSK) Prescription Drugs Product Offerings
Table 80. GlaxoSmithKline (GSK) Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. GlaxoSmithKline (GSK) Key News & Latest Developments
Table 82. Amgen Company Summary
Table 83. Amgen Prescription Drugs Product Offerings
Table 84. Amgen Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Amgen Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca Prescription Drugs Product Offerings
Table 88. AstraZeneca Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Bristol-Myers Squibb Company Summary
Table 91. Bristol-Myers Squibb Prescription Drugs Product Offerings
Table 92. Bristol-Myers Squibb Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Bristol-Myers Squibb Key News & Latest Developments
Table 94. Eli Lilly Company Summary
Table 95. Eli Lilly Prescription Drugs Product Offerings
Table 96. Eli Lilly Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Eli Lilly Key News & Latest Developments
Table 98. Teva Company Summary
Table 99. Teva Prescription Drugs Product Offerings
Table 100. Teva Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Teva Key News & Latest Developments
Table 102. Bayer Company Summary
Table 103. Bayer Prescription Drugs Product Offerings
Table 104. Bayer Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Bayer Key News & Latest Developments
Table 106. Novo Nordisk Company Summary
Table 107. Novo Nordisk Prescription Drugs Product Offerings
Table 108. Novo Nordisk Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Novo Nordisk Key News & Latest Developments
Table 110. Allergan Company Summary
Table 111. Allergan Prescription Drugs Product Offerings
Table 112. Allergan Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Allergan Key News & Latest Developments
Table 114. Takeda Company Summary
Table 115. Takeda Prescription Drugs Product Offerings
Table 116. Takeda Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Takeda Key News & Latest Developments
Table 118. Boehringer Ingelheim Company Summary
Table 119. Boehringer Ingelheim Prescription Drugs Product Offerings
Table 120. Boehringer Ingelheim Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Boehringer Ingelheim Key News & Latest Developments
Table 122. Takeda Company Summary
Table 123. Takeda Prescription Drugs Product Offerings
Table 124. Takeda Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Takeda Key News & Latest Developments
Table 126. Prescription Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Prescription Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Prescription Drugs Production by Region, 2018-2023 (K Units)
Table 129. Global Prescription Drugs Production by Region, 2024-2029 (K Units)
Table 130. Prescription Drugs Market Opportunities & Trends in Global Market
Table 131. Prescription Drugs Market Drivers in Global Market
Table 132. Prescription Drugs Market Restraints in Global Market
Table 133. Prescription Drugs Raw Materials
Table 134. Prescription Drugs Raw Materials Suppliers in Global Market
Table 135. Typical Prescription Drugs Downstream
Table 136. Prescription Drugs Downstream Clients in Global Market
Table 137. Prescription Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prescription Drugs Segment by Type in 2022
Figure 2. Prescription Drugs Segment by Application in 2022
Figure 3. Global Prescription Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prescription Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prescription Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Prescription Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prescription Drugs Revenue in 2022
Figure 9. By Type - Global Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Prescription Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Prescription Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Prescription Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Prescription Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Prescription Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Prescription Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Prescription Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Prescription Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Prescription Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Prescription Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Prescription Drugs Sales Market Share, 2018-2029
Figure 23. US Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Prescription Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Prescription Drugs Sales Market Share, 2018-2029
Figure 28. Germany Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Prescription Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Prescription Drugs Sales Market Share, 2018-2029
Figure 37. China Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Prescription Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Prescription Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Prescription Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Prescription Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Prescription Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Prescription Drugs by Region, 2022 VS 2029
Figure 54. Prescription Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

処方薬とは、医師や歯科医師などの資格を持つ専門家が、患者の健康状態や病歴を考慮した上で処方する医薬品を指します。市販薬と異なり、処方薬は特定の疾患や症状に応じて処方されるため、その使用には専門的な知識が求められます。ここでは、処方薬の定義、特徴、種類、用途、関連技術について詳しく解説します。

まず、処方薬の定義ですが、医師が患者に対して必要と判断した医薬品を指示することにより、患者が薬局で受け取ることができる薬です。処方薬は、特定の疾患治療を目的としているため、他の薬剤とは異なり、自己判断で使用することができません。

次に、処方薬の特徴について考えます。処方薬は、主に以下のような特徴を持っています。一つ目は、安全性です。処方薬は、専門家によって患者の症状や健康状態を評価した上で処方されるため、一般的には使用に伴うリスクが低減されます。二つ目は、個別性です。同じ病気であっても、患者ごとに状態や体質が異なるため、処方薬はその患者に特有のニーズに応じて調整されます。三つ目は、薬剤の種類によっては、使用に際して慎重な観察が必要であることです。例えば、抗生物質や精神科の薬など、一部の薬剤は副作用や依存のリスクが高いため、医師の管理下で使用される必要があります。

処方薬の種類は多岐にわたりますが、主に次のようなカテゴリに分類されます。まず、内服薬である錠剤、カプセル、液体などがあります。これらは、消化器系を通じて体内に吸収され、全身的な効果を発揮します。次に、外用薬としてクリームや軟膏、貼付剤があり、これらは皮膚や粘膜に直接適用されることで局所的な治療を行います。また、注射剤も処方薬の一つであり、特に速やかな効果を求められる場合や、経口摂取が困難な患者に対して使用されます。これらの薬剤は、それぞれ異なる作用機序や副作用があるため、適切な選択が求められます。

処方薬の用途は、おもに疾患の治療や予防にあります。例えば、抗生物質は細菌感染に対する治療に使われ、抗ウイルス薬はウイルス性感染症の治療に使用されます。また、抗うつ薬や抗不安薬は、精神的な疾患の治療に使われることが多いです。さらに、慢性疾患（例えば、高血圧や糖尿病）の管理に使われる薬剤も多く、これらは患者が長期にわたって服用し続けることが必要になります。

また、処方薬には、特定の用途に応じた新しい治療薬の開発が進んでいます。最近では、抗体医薬品や遺伝子治療薬、細胞治療薬などの高度な生物医薬品が登場しています。これらは、従来の治療法よりも高い効果を示すことがあり、特定の疾患に対する新たな治療の選択肢として期待されています。

関連技術に関しては、薬の処方・製剤技術や投与技術が挙げられます。処方の際には、患者の病歴やアレルギー歴などを考慮した上で、最適な薬剤を選択する必要があります。また、製剤技術も進化しており、薬剤の吸収率や持続時間を向上させるための新たな製剤方法が研究されています。さらに、投与技術の面では、経口投与だけでなく、経皮吸収や吸入などの多様な投与方法が開発されており、それぞれの患者にとって最も適した方法を選ぶことができるようになっています。

最後に、処方薬の取り扱いに関する注意点についても触れておきます。患者は処方薬を自己判断で中断したり、他の薬と併用したりすることは避けるべきです。これにより、副作用や相互作用のリスクが増す可能性があります。また、処方薬は正しく保存し、使用期限を守ることが重要です。未使用の薬剤は適切に廃棄し、他者に譲らないことも大切です。

このように、処方薬は病気の治療や予防に不可欠なものであり、その使用には専門的な知識と注意が必要です。今後も新たな薬剤や治療法が登場し、患者にとっての選択肢が広がっていくことが期待されます。医師とのコミュニケーションを大切にし、自分の健康管理を行うことが重要です。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 処方薬の世界市場見通し2023年-2029年(Prescription Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

処方薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp